The clinical benefit of targeting the complement system has been established for many rare clinical disorders and the past few years have been a highly successful and exciting period for the field of complement-directed drug discovery and development.
Svar has over 15 years’ experience of complement system assay development. Our complement system assays have been developed by our experienced scientists in close collaboration with key opinion leaders, to yield sensitive, reliable and easy-to-use products for the exploration of most aspects of the complement system.
The Svar Complement activity biomarkers give valuable intelligence in several situations where one might suspect that complement activation plays a role in the disorder. They are developed to target the unique neoepitopes only presented at the complement component or complex when activated.
By listening to your requirements, we can propose a solution specifically for your needs. Contact us today to speak to one of our scientific experts and find out how our complement system solutions can help with your projects in 2020.